U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07179991) titled 'DDAVP Effect by TEG6 in Cardiac Surgery' on Sept. 11.
Brief Summary: Cardiopulmonary bypass (CPB) is a process that uses a pump that temporarily takes over the function of the heart and lungs during cardiac surgery to maintain blood circulation and oxygenation. Using CPB during cardiac surgery can result in complications with blood clotting. Blood clotting is achieved when molecules in the blood, called platelets, are able to form together with the help of other clotting factors to form a clot. A drug called desmopressin (DDAVP) is used to help blood clot properly by increasing the amount of clotting factors in the blood. Several s...